President Trump used a public appearance to promote a federal initiative called the GENEROUS model, presented as a program intended to provide lower drug prices to state Medicaid programs. The announcement was reported from Washington and framed as part of the administration’s efforts to address drug pricing, but the accessible portion of the source article provided limited operational detail.
According to the STAT News report, President Trump declared that all 50 states, Washington, D.C., and Puerto Rico would participate in the GENEROUS model. The coverage characterizes the statement as an effort to tout the initiative but notes that the public announcement left multiple questions unanswered. The article included a photograph of the president speaking about GENEROUS in the Oval Office and attributed the reporting to John Wilkerson, dated Sept. 18, 2026.
The Centers for Medicare and Medicaid Services (CMS) provided a separate statement confirming that, as of its posting, 40 states and Puerto Rico had signed agreements to participate in the GENEROUS model. The STAT excerpt indicates that other states had applied to participate but had not yet signed agreements at the time of reporting. The CMS announcement was linked in the source article as the agency reporting those participation figures.
The open excerpt reports that states have until the end of the month to sign agreements to participate in the model. Beyond that deadline information, the accessible content does not provide further specifics on implementation timelines, start dates for discounted pricing, or administrative steps the states or federal agencies will take after signatures are finalized.
The source article explicitly states that the public announcement “left many questions unanswered.” The excerpt does not include key operational details such as:
Because these items were not reported in the accessible portion of the STAT article, readers should consider them unprovided by the source rather than absent in official program documentation.
The article positions the GENEROUS model as an administration initiative intended to lower drug costs for Medicaid programs. Beyond the announcement and the CMS participation status, the public excerpt does not include evidence, projections, or third-party analysis of the program’s likely impact. Any discussion of potential downstream effects — on Medicaid budgets, beneficiary cost-sharing, or pharmaceutical market behavior — would be speculative if not grounded in additional reporting or documents that were not available in the source excerpt.
The STAT News piece is credited to John Wilkerson, Washington correspondent, and is dated Sept. 18, 2026. The accessible portion of the article links to a CMS press release for participation numbers. The STAT article also indicates that the remainder of the story is available behind the STAT+ paywall; consequently, the excerpt used here does not include the full reporting contained in the subscription portion. Where the accessible source did not report specifics, this rewrite notes those omissions rather than supplying unreported details.
In summary, the public reporting in the accessible excerpt records a high-profile announcement by President Trump that framed the GENEROUS model as involving nationwide participation by states, the District of Columbia, and Puerto Rico, and cites a CMS statement that 40 states plus Puerto Rico had signed participation agreements with other states having applied. The article makes clear that many program details were not provided in the open coverage and that fuller reporting exists behind the STAT+ subscription, which is outside the scope of the provided source excerpt.
(Author and reporting: John Wilkerson, STAT News; Sept. 18, 2026. The open excerpt linked a CMS press release; additional details referenced in the original article’s paywalled portion were not available in the provided source.)